Analgesics - Philippines | Statista Market Forecast

In the Philippines, the revenue generated in the Analgesics market in 2024 amounts to US$191.60m.
It is projected that the market will experience an annual growth rate of 10.32% from 2024 to 2029 (CAGR 2024-2029).
When compared to other countries worldwide, the United States generates the highest revenue in the Analgesics market, with US$7.24bn in 2024.
Taking into account the total population figures, in the Philippines, the per person revenue in the Analgesics market amounts to US$1.61 in 2024.
In the Philippines, the demand for over-the-counter analgesics is rising due to the increasing prevalence of chronic pain conditions.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Philippines is witnessing significant growth and development, driven by various factors such as changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences: In Philippines, customers have shown a growing preference for over-the-counter (OTC) analgesics due to their convenience and accessibility. With a busy lifestyle and increasing awareness about self-medication, consumers are opting for OTC analgesics to manage common ailments such as headaches, muscle pain, and fever. Additionally, customers are also seeking analgesics that provide quick relief and have minimal side effects.

Trends in the market: One of the emerging trends in the Analgesics market in Philippines is the increasing demand for natural and herbal pain relief products. Customers are becoming more conscious about the ingredients used in analgesics and are opting for products that are derived from natural sources. This trend is driven by the growing preference for holistic healthcare and the belief that natural remedies are safer and have fewer side effects.Another trend observed in the market is the rising popularity of topical analgesics. These products, such as creams, gels, and patches, are applied directly to the affected area for targeted pain relief. Topical analgesics are gaining traction among customers due to their ease of use and localized action, making them suitable for specific pain management needs.

Local special circumstances: The Analgesics market in Philippines is also influenced by local special circumstances. The country has a large population with a high prevalence of common ailments such as headaches and muscle pain. This creates a significant demand for analgesics, driving market growth. Additionally, the Philippines has a growing middle class with increasing disposable income, which further contributes to the expansion of the market.

Underlying macroeconomic factors: The growth of the Analgesics market in Philippines is supported by several underlying macroeconomic factors. The country's economic development and rising healthcare expenditure have led to improved access to healthcare services, including pharmaceutical products. Furthermore, the government's initiatives to promote self-medication and improve healthcare infrastructure have positively impacted the market.In conclusion, the Analgesics market in Philippines is experiencing growth and development due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. Customers in Philippines are increasingly opting for OTC analgesics, with a growing preference for natural and herbal products. The market is also witnessing a rise in the popularity of topical analgesics. The local special circumstances, such as the high prevalence of common ailments and the growing middle class with increased disposable income, contribute to the market's growth. Additionally, the underlying macroeconomic factors, including economic development and government initiatives, support the expansion of the Analgesics market in Philippines.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.